SEC Filing Summary

David R. Pelizzon, a 10% owner, director, and officer of ORTHOPEDIATRICS CORP, reported the sale of 22,500 shares of common stock on September 2, 2026. The sale was executed at a weighted average price of $23.35 per share, with transactions ranging from $23.01 to $23.74. Following the sale, Mr. Pelizzon directly owns 44,384 shares. The footnote indicates that the sale was conducted by Squadron Capital LLC to fund other business ventures. Mr. Pelizzon may be deemed beneficial owner of shares held by Squadron Capital LLC but expressly disclaims such ownership except for any pecuniary interest. The reported post-transaction shares of 6,504,133 appears to be incorrect based on the provided data.